Orphan drug designation, or ODD, is valuable on both a humanitarian and a profitability basis. And this company is seeing shares rally following news that it was granted the designation for the...

To read the full story on AllPennyStocks.com, click here.

Cardiol Therapeutics (NASDAQ:CRDL)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024 Click aqui para mais gráficos Cardiol Therapeutics.
Cardiol Therapeutics (NASDAQ:CRDL)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024 Click aqui para mais gráficos Cardiol Therapeutics.